X-GENICS LIMITED

Company Registration Number:
04218236 (England and Wales)

Unaudited abridged accounts for the year ended 31 May 2024

Period of accounts

Start date: 01 June 2023

End date: 31 May 2024

X-GENICS LIMITED

Contents of the Financial Statements

for the Period Ended 31 May 2024

Company Information - 3
Report of the Directors - 4
Balance sheet - 5
Additional notes - 7

X-GENICS LIMITED

Company Information

for the Period Ended 31 May 2024




Director: Bharat Patel
Registered office: Kemp House
160 City Road
London
England
EC1V 2NX
Company Registration Number: 04218236 (England and Wales)

X-GENICS LIMITED

Directors' Report Period Ended 31 May 2024

The directors present their report with the financial statements of the company for the period ended 31 May 2024

Directors

The directors shown below have held office during the whole of the period from 01 June 2023 to 31 May 2024
Bharat Patel

This report was approved by the board of directors on 9 February 2025
And Signed On Behalf Of The Board By:

Name: Bharat Patel
Status: Director

X-GENICS LIMITED

Balance sheet

As at 31 May 2024


Notes

2024
£

2023
£
Fixed assets
Total fixed assets: - -
Current assets
Debtors: 0 453
Cash at bank and in hand: 44,709 65,556
Total current assets: 44,709 66,009
Creditors: amounts falling due within one year: ( 170 ) ( 0 )
Net current assets (liabilities): 44,539 66,009
Total assets less current liabilities: 44,539 66,009
Creditors: amounts falling due after more than one year: ( 265,347 ) ( 284,465 )
Total net assets (liabilities): ( 220,808 ) ( 218,456 )

The notes form part of these financial statements

X-GENICS LIMITED

Balance sheet continued

As at 31 May 2024


Notes

2024
£

2023
£
Capital and reserves
Called up share capital: 100,000 100,000
Profit and loss account: ( 320,808 ) ( 318,456 )
Shareholders funds: ( 220,808 ) ( 218,456 )

For the year ending 31 May 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 9 February 2025
And Signed On Behalf Of The Board By:

Name: Bharat Patel
Status: Director

The notes form part of these financial statements

X-GENICS LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

X-GENICS LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2024

  • 2. Employees


    2024

    2023
    Average number of employees during the period 1 1

X-GENICS LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2024

  • 3. Off balance sheet disclosure

    No